Login
Roast topics
Find topics
Find it!
From:
ECOG-ACRIN Cancer Research Group
(Uncensored)
subscribe
EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer
https://ecog-acrin.org/tea5181-trial-finds-no-survival-benefit-for-concurrent-and-consolidative-durvalumab-vs-consolidation-alone-in-unresectable-non-small-cell-lung-cancer/
links
backlinks
Tagged with:
cancer treatment
lung cancer
clinical trial
news stories
research results
Roast topics
Find topics
Roast it!
The post EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer appeared first on ECOG-ACRIN Cancer Research Group.
